Typcal
Development of mycelium protein through fermentation
Patented technology based on the circular economy, delivering health for people and sustainability for the planet!
Introducing Typcal, a Brazilian pioneering foodtech company specializing in alternative protein. Their journey began in 2021 with a focus on plant-based products; however, they swiftly recognized the limitations within that category – processed food, high costs, lack of a clean label, and minimal environmental impact. In response, they embarked on a mission to revolutionize the industry by developing a groundbreaking technology that utilizes mycelium to replicate whole cuts. While their technology is currently patent pending, they're excited to announce the availability of their first product. Not only does it match the affordability of traditional meat, but it also boasts just three ingredients, making it a healthier alternative to any other protein option on the market.
Yet, Typcal's ambition extends beyond consumer products. They aspire to contribute to the B2B market by creating a mycelium protein in collaboration with the food and meat industry, enhancing the quality of their products. To produce this protein, Typcal utilizes discarded yeast from breweries as a substrate for the mycelium, promoting sustainability and resource efficiency.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Interview with Professor Jack Pronk: About the Intersection of Academia and Entrepreneurship in Industrial Biotechnology
Jack Pronk is full professor in Industrial Microbiology and the head of the Biotechnology Department at TU Delft. His research focuses on understanding enhancing microbial performance in industrial processes by integrating quantitative physiology, genomics, synthetic biology, and evolutionary engineering. His team's work on yeast engineering for alcoholic fermentation and improving ethanol yields is applied on an industrial scale. Recently, he was awarded the prestigious Novozymes Prize, given annually since 1963 for outstanding European research in biotechnology. Planet B.io had the opportunity to sit down with Professor Pronk to discuss his views on entrepreneurship in industrial biotechnology.
Hologenomix | Pioneering Multi-Omics Profiles for Early Disease Diagnosis
Hologenomix, the newest resident at Planet B.io, is creating multi-omics profiles from human biofluids. As the first user of our Shared Service Lab, Hologenomix is poised to revolutionize early disease diagnosis through DNA analysis. Co-founders David Calderon Franco and Eric van der Toorn share insights into their journey and vision.
Fishway: Innovating the Future of Fish through Cellular Aquaculture
Fishway, member of Planet B.io, is the new kid on the block in the field of cellular aquaculture. Founded by Nina Coolsaet and Sam Van de Velde, Fishway aims to address the pressing challenges faced by the traditional fishing industry, such as overfishing, pollution, and the decline in biodiversity. By producing fish-derived ingredients, Fishway hopes to offer a sustainable alternative that preserves the nutritional benefits of fish without the environmental downsides.